Repetitive transcranial magnetic stimulation modulates long-range functional connectivity in autism spectrum disorder, published April 2023
“The findings of this study demonstrate that high-frequency rTMS over the parietal lobe is potentially an effective strategy to improve core symptoms by enhancing long-range connectivity reorganization in ASD.”
Impact of repetitive transcranial magnetic stimulation on the directed connectivity of autism EEG signals: a pilot study, published December 2022
“rTMS provides changes in connectivity and behavior, suggesting its potential use as a viable treatment option for ASD individuals.”
Exploratory Study of rTMS Neuromodulation Effects on Electrocortical Functional Measures of Performance in an Oddball Test and Behavioral Symptoms in Autism, May 28, 2018
“Our results suggest that rTMS, particularly after 18 sessions, facilitates cognitive control, attention and target stimuli recognition by improving discrimination between task-relevant and task-irrelevant illusory figures in an oddball test. The noted improvement in executive functions of behavioral performance monitoring further suggests that TMS has the potential to target core features of ASD.”
Study of the role of the transcranial magnetic stimulation on language progress in autism spectrum disorder, June 2021
“There was a statistically significant clinical improvement in patients receiving active TMS comparing baseline Childhood Autism Rating Scale (CARS) assessment and after treatment.
“There was significant difference in improvement between the two groups according to eye contact. There was significant improvement in response to examiner. There was significant difference in improvement between the two groups according to active expressive language.
“Conclusion: Repetitive transcranial magnetic stimulation (rTMS) over left inferior frontal gyrus may be a safe and effective way of improving language of ASD. The joint application of rTMS and standard language therapy may lead to more rapid improvement in the language progress of children with ASD.”
Effects of repetitive transcranial magnetic stimulation on children with low-function autism, Nov 2019
“These findings supported our hypothesis by demonstration of positive effects of combined rTMS neurotherapy in active treatment group as compared to the waitlist group, as the rTMS group showed significant improvements in behavioral and functional outcomes as compared to the waitlist group.”
Outcomes from Individual Alpha Frequency Guided Repetitive Transcranial Magnetic Stimulation in Children with Autism Spectrum Disorder – A Retrospective Chart Review. – Uchenna Ezedinma1, Piotr Swierkowski2, Shauna Fjaagesund, 2022.
Conclusion: This study presents evidence on the efficacy and safety of α-rTMS in improving ASD symptoms, quality of life and comorbid sleep troubles in children. However, these findings should be interpreted as preliminary pending the presentation of double-blind, randomised clinical trials.”
The Potential of Magnetic Resonant Therapy in Children with Autism Spectrum Disorder,” in Austin Publishing Group, August 2016.
“Given our understanding of the EEG and the consistent abnormalities in the electrophysiology of children with ASD, we would suggest that MRT [MeRT] is an appropriate therapeutic option to further pursue. The existing literature in depression and posttraumatic stress disorder in addition to preliminary studies in children with ASD all support its potential impact as a therapeutic option.”
Predicting the long-term after-effects of rTMS in autism spectrum disorder using temporal variability analysis of scalp EEG, published October 28, 2019
“Repetitive transcranial magnetic stimulation (rTMS) emerges as a useful therapy for autism spectrum disorder (ASD) clinically.”
“The results showed the hyper-variability in the resting-state networks of ASD patients, while three week rTMS treatment alleviates the hyper fluctuations occurring in the frontal-parietal and frontal-occipital connectivity and further contributes to the ameliorative ASD symptoms. In addition, the changes in variability network properties are closely correlated with clinical scores, which further serve as potential predictors to reliably track the long-term rTMS efficacy for ASD.Significance.The findings consistently demonstrated that the temporal variability of time-varying networks of ASD patients could be modulated by rTMS, and related variability properties also help predict follow-up rTMS efficacy, which provides the potential for formulating individualized treatment strategies for ASD”